PREVALENCE OF HEPATITIS A IN B AMONG BLOOD DONORS WITH HISTORY OF JAUNDICE

Authors

  • Božislava Majcen Vivod Oddelek za transfuziologijo in imunohematologijo Splošna bolnišnica Maribor Ljubljanska 5 2000 Maribor
  • Vera Urlep Šalinović Oddelek za transfuziologijo in imunohematologijo Splošna bolnišnica Maribor Ljubljanska 5 2000 Maribor

DOI:

https://doi.org/10.6016/ZdravVestn.2287

Keywords:

blood donors, questionnaire, jaundice, hepatitis A, B

Abstract

Background. Preventing transmission of infectious disease through blood transfusion presents one of the greatest challenges of transfusion medicine. All donations are monitored for syphilis since 1960, hepatitis B (HBsAg) since 1970, aids (anti HIV) since 1986 and hepatitis C (anti-HCV) since 1993.

After introducing a donor questionnaire in 1994, we started to test all donors with a history of hepatitis for anti-HBc, antiHBs antibodies, and antibodies against hepatitis A (anti-HAV).

Methods. Data on donors were found in the Datec computer program which is commonly used in all transfusion institutions in Slovenia.
Results. Among 43,000 registered donors, 764 (1.78%) had a history of hepatitis. After testing, we found 666 of them positive (87.2%) for hepatitis A or B antibodies. 654 (85.6%) donors had hepatitis A antibodies and 98 (12.8%) had anti-HBc antibodies. Among these 98, 30 donors (30.6%) had no anti-HBs antibodies. 86 donors (11%) had antibodies against hepatitis A and B.

Conclusions. After additional testing of donors for hepatitis B antibodies, we excluded 30 (0.069%) HBsAg negative, antiHBc positive and anti-HBs negative donors with history of hepatitis.

Downloads

Download data is not yet available.

References

Svet Evrope. Izbira dajalcev. Priporočila o pripravi, uporabi in zagotavljanju kakovosti komponent krvi. 9. izdaja. Ljubljana: Zavod RS za transfuzijsko medicino, 2003: 29–49.

Levičnik-Stezinar S, Baraga L, Hrašovec V, Kavaš E, Kramar I, Slokan M, Urlep-Šalinović V, Šunjevarič M. Presejalno testiranje kot ukrep za zagotavljanje varne transfuzije. Zdrav Var 1998; 37: 527–30.

Majcen-Vivod B, Urlep-Šalinović V, Jelatancev B. Prenos hepatitisov B in C s krvjo v triletnem obdobju od 1996 do 1998. Med Razgl 2000; 39: Suppl 5: 3–8.

Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Scientific Publications, 1997: 510–25.

Kann M, Gerlich WH. Hepatitis B. In: Topley and Wilson’s microbiology and microbial infections. 9th ed. Volume 1, Virology. Avon: Bath Press, 1998: 745–73.

Van der Poel CL. Screening for the hepatits viruses. In: Barbara JAJ, Sultsman MK, Rossi U. Proceedings of the ESTM residential course. Pärnu: ESTM, 1998: 7–31.

Walker RH ed. Technical manual of American Association of Blood Banks. 12th ed. Bethesda: American Association of Blood Banks, 1996: 564–6.

Krusius T. Blood donor screening for anti-HBc to prevent transfusion transmitted infection. In: Barbara JAJ, Sultsman MK, Rossi U. Proceedings of the ESTM residential course. Pärnu: ESTM, 1998: 55–61.

Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion transmitted viral infections. N Engl J Med 1996; 334: 1685–90.

Murphy EL, Busch MP, Tong M, Cornett P, Vyas GN. A prospective study of the risk of transfusion-acquired viral infections. Transf Med 1998; 8: 173–8.

Barbara JAJ. Introduction: range of agents and their properties. In: Barbara JAJ, Sultsman MK, Rossi U. Proceedings of the ESTM residential course. Pärnu: ESTM, 1998: 1–3.

Erhard S, Roth WK. Feasibility, efficacy and economy of NAT testing in Germany. In: Plenary state of the art book. VIII European Congress of the International Society of Blood Transfusion. Istanbul: International Society of Blood Transfusion, 2003: 27–8.

Robertson HB, Lemon SM. Hepatitis A and E. In: Collier L, Balows A, Sussman M. Topley and Wilson’s microbiology and microbial infections. 9th ed. Vol. 1 Virology. Avon: Bath Press, 1998: 693–716.

Evarus H. Clinical importance of blood safety. In: Barbara JAJ, Sultsman MK, Rossi U. Proceedings of ESTM residential course. Pärnu: ESTM, 1998: 11–21.

Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele S. Transmission of hepatitis A to patients with haemophilia by factor VIII concentrate treated with organic solvent and detergent to inactivate viruses. Ann Intern Med 1994; 120: 1–7.

Parkkinen J. Viral inactivation procedures of plasma products. In: Barbara JAJ, Sultsman MK, Rossi U. Proceedings of the ESTM residential course. Pärnu: ESTM, 1998: 187–91.

Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Hematol 1999; 107: 186–95.

Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T, Ikeda H. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transf Med 2001; 41: 1107–13.

Hiroshi Y et al. Frequent presence of HBV in the sera of HBsAg negative, anti-HBc positive blood donors. Transf Med 2001; 41: 1093–9.

Majcen-Vivod B. Spremljanje prenosa hepatitisov A, B in C s krvjo v SB Maribor v triletnem obdobju od 1996–1998. Specialistična naloga. Maribor: Splošna bolnišnica, 2000: 28–39.

Prodinger WM, Larcher C, Solder BM, Geissler D, Dierich MP. Hepatitis A in Western Austria – the epidemiologic situation before the introduction of active immunisation. Infection 1994; 22: 53–5.

Glaser E. Kri in krvni izdelki skozi lupo zakonskih in drugih predpisov Evropske zveze. Zdrav Vestn 1996; 65: 695–7.

Issue

Section

Professional Article

How to Cite

1.
PREVALENCE OF HEPATITIS A IN B AMONG BLOOD DONORS WITH HISTORY OF JAUNDICE. ZdravVestn [Internet]. 2004 Apr. 25 [cited 2024 Nov. 2];73(4). Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/2287